Cargando…

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model

SIMPLE SUMMARY: Ductal carcinoma in situ (DCIS) patients have an excellent overall survival rate and over-treatment is always a cause for concern due to potential side-effects. Standard clinicopathological parameters have limited value in predicting breast cancer events (BCEs) and stratification of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghose, Soumya, Cho, Sanghee, Ginty, Fiona, McDonough, Elizabeth, Davis, Cynthia, Zhang, Zhanpan, Mitra, Jhimli, Harris, Adrian L., Thike, Aye Aye, Tan, Puay Hoon, Gökmen-Polar, Yesim, Badve, Sunil S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093091/ https://www.ncbi.nlm.nih.gov/pubmed/37046583 http://dx.doi.org/10.3390/cancers15071922

Ejemplares similares

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
por: Badve, Sunil S., et al.
Publicado: (2022)

Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast
por: Badve, Sunil S., et al.
Publicado: (2021)

Is conservative management of ductal carcinoma in situ risky?
por: Zheng, Lan, et al.
Publicado: (2022)

Single cell heterogeneity in ductal carcinoma in situ of breast
por: Gerdes, Michael J, et al.
Publicado: (2017)

Upregulation of HSF1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2016)

More microinvasive foci in larger tumours of breast ductal carcinoma in situ
por: Chen, Xiao-Yang, et al.
Publicado: (2022)

CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
por: Craven, Kelly E., et al.
Publicado: (2021)

Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
por: Gökmen-Polar, Yesim, et al.
Publicado: (2015)

Thymic Carcinomas and Second Malignancies: A Single-Center Review
por: Badve, Sunil S., et al.
Publicado: (2021)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues
por: Chen, Yi, et al.
Publicado: (2019)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2018)

Common genetic susceptibility to DCIS and invasive ductal carcinoma
por: Sopik, Victoria, et al.
Publicado: (2016)

ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing
por: Buechler, Steven A., et al.
Publicado: (2020)

Spatially variant immune infiltration scoring in human cancer tissues
por: Allam, Mayar, et al.
Publicado: (2022)

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)
por: Punglia, Rinaa S, et al.
Publicado: (2018)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions
por: Tan, Wai Jin, et al.
Publicado: (2016)

GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
por: Khanna, Puja, et al.
Publicado: (2017)

Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type
por: Padda, Sukhmani K., et al.
Publicado: (2021)

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast
por: Teo, N B, et al.
Publicado: (2002)

Paget's disease of the male breast with underlying ductal carcinoma in situ (‘DCIS’)
por: Choudhury, Bhuban, et al.
Publicado: (2015)

Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice
por: Lam, Runyi Adeline, et al.
Publicado: (2021)

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor–Positive, Early Breast Cancer
por: Buechler, Steven A, et al.
Publicado: (2019)

Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray
por: Lee, Ming, et al.
Publicado: (2021)

CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
por: Chong, Tsung Wen, et al.
Publicado: (2015)

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells
por: Volinia, Stefano, et al.
Publicado: (2018)

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
por: Wärnberg, Fredrik, et al.
Publicado: (2021)

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
por: Johnson, C, et al.
Publicado: (2012)

The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast
por: Villanueva, Hugo, et al.
Publicado: (2018)

Improving Therapeutic Ratios with the Oncotype DX® Ductal Carcinoma In Situ (DCIS) Score
por: Lalani, Nafisha, et al.
Publicado: (2017)

Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion
por: Wan, Zhi-Bin, et al.
Publicado: (2018)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
por: Lau, Hannah Si Hui, et al.
Publicado: (2023)

Molecular Analysis of Thymoma
por: Badve, Sunil, et al.
Publicado: (2012)

Effect of Quantitative Nuclear Image Features on Recurrence of Ductal Carcinoma In Situ (DCIS) of the Breast
por: Axelrod, David E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_lff0p60ppct7467kpt5ktl95jj